Signal enhancement ratio of multi-phase contrast-enhanced MRI: an imaging biomarker for survival in pancreatic adenocarcinoma.
Xia C, Qu JR, Jiao YP, Lu CQ, Zhao B, Ge RJ, Qiu Y, Cao BY, Yu Q, Xia TY, Meng XP, Song Y, Zhang LH, Long XY, Ye J, Ding ZM, Cai W, Ju SH.
Xia C, et al. Among authors: ju sh.
Eur Radiol. 2024 Nov;34(11):7460-7470. doi: 10.1007/s00330-024-10746-z. Epub 2024 May 15.
Eur Radiol. 2024.
PMID: 38750169
Free PMC article.